• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 AI 和 AIBP 协同抗炎作为血管疾病治疗的新视角。

Apolipoprotein-AI and AIBP synergetic anti-inflammation as vascular diseases therapy: the new perspective.

机构信息

Department of Biochemistry and Molecular Biology, University of South China, Hengyang, 421001, Hunan Province, China.

International College, University of South China, Hunan Province, Hengyang, 421001, China.

出版信息

Mol Cell Biochem. 2021 Aug;476(8):3065-3078. doi: 10.1007/s11010-020-04037-6. Epub 2021 Apr 3.

DOI:10.1007/s11010-020-04037-6
PMID:33811580
Abstract

Vascular diseases (VDs) including pulmonary arterial hypertension (PAH), atherosclerosis (AS) and coronary arterial diseases (CADs) contribute to the higher morbidity and mortality worldwide. Apolipoprotein A-I (Apo A-I) binding protein (AIBP) and Apo-AI negatively correlate with VDs. However, the mechanism by which AIBP and apo-AI regulate VDs still remains unexplained. Here, we provide an overview of the role of AIBP and apo-AI regulation of vascular diseases molecular mechanisms such as vascular energy homeostasis imbalance, oxidative and endoplasmic reticulum stress and inflammation in VDs. In addition, the role of AIBP and apo-AI in endothelial cells (ECs), vascular smooth muscle (VSMCs) and immune cells activation in the pathogenesis of VDs are explained. The in-depth understanding of AIBP and apo-AI function in the vascular system may lead to the discovery of VDs therapy.

摘要

血管疾病(VDs)包括肺动脉高压(PAH)、动脉粥样硬化(AS)和冠状动脉疾病(CADs),导致全球更高的发病率和死亡率。载脂蛋白 A-I(Apo A-I)结合蛋白(AIBP)和 Apo-AI 与 VDs 呈负相关。然而,AIBP 和 apo-AI 调节 VDs 的机制仍不清楚。在这里,我们概述了 AIBP 和 apo-AI 调节血管疾病的分子机制,如血管能量平衡失衡、氧化和内质网应激以及炎症在 VDs 中的作用。此外,还解释了 AIBP 和 apo-AI 在血管疾病发病机制中对内皮细胞(ECs)、血管平滑肌(VSMCs)和免疫细胞激活的作用。深入了解 AIBP 和 apo-AI 在血管系统中的功能可能会导致发现 VDs 的治疗方法。

相似文献

1
Apolipoprotein-AI and AIBP synergetic anti-inflammation as vascular diseases therapy: the new perspective.载脂蛋白 AI 和 AIBP 协同抗炎作为血管疾病治疗的新视角。
Mol Cell Biochem. 2021 Aug;476(8):3065-3078. doi: 10.1007/s11010-020-04037-6. Epub 2021 Apr 3.
2
Apolipoprotein A-1 Binding Protein Inhibits Inflammatory Signaling Pathways by Binding to Apolipoprotein A-1 in THP-1 Macrophages.载脂蛋白 A-1 结合蛋白通过与 THP-1 巨噬细胞中的载脂蛋白 A-1 结合来抑制炎症信号通路。
Circ J. 2018 Apr 25;82(5):1396-1404. doi: 10.1253/circj.CJ-17-0877. Epub 2018 Apr 3.
3
Apolipoprotein A-1 binding protein promotes macrophage cholesterol efflux by facilitating apolipoprotein A-1 binding to ABCA1 and preventing ABCA1 degradation.载脂蛋白A-1结合蛋白通过促进载脂蛋白A-1与ABCA1结合并防止ABCA1降解来促进巨噬细胞胆固醇外流。
Atherosclerosis. 2016 May;248:149-59. doi: 10.1016/j.atherosclerosis.2016.03.008. Epub 2016 Mar 9.
4
Regulation of lipid rafts, angiogenesis and inflammation by AIBP.AIBP 对脂筏、血管生成和炎症的调节。
Curr Opin Lipidol. 2019 Jun;30(3):218-223. doi: 10.1097/MOL.0000000000000596.
5
Apolipoprotein A-I Binding Protein Inhibits the Formation of Infantile Hemangioma through Cholesterol-Regulated Hypoxia-Inducible Factor 1α Activation.载脂蛋白 A-I 结合蛋白通过胆固醇调节的缺氧诱导因子 1α 激活抑制婴幼儿血管瘤的形成。
J Invest Dermatol. 2024 Mar;144(3):645-658.e7. doi: 10.1016/j.jid.2023.07.030. Epub 2023 Oct 11.
6
Apo AI Nanoparticles Delivered Post Myocardial Infarction Moderate Inflammation.载脂蛋白 AI 纳米颗粒递送至心肌梗死后的中度炎症部位。
Circ Res. 2020 Nov 6;127(11):1422-1436. doi: 10.1161/CIRCRESAHA.120.316848. Epub 2020 Sep 21.
7
AIBP augments cholesterol efflux from alveolar macrophages to surfactant and reduces acute lung inflammation.AIBP 增强肺泡巨噬细胞向表面活性剂的胆固醇外流,减少急性肺炎症。
JCI Insight. 2018 Aug 23;3(16). doi: 10.1172/jci.insight.120519.
8
[Plasma apolipoproteins B and AI in healthy individuals and patients with coronary atherosclerosis in a male population from Lithuania].[立陶宛男性人群中健康个体及冠状动脉粥样硬化患者的血浆载脂蛋白B和载脂蛋白AI]
Kardiologiia. 1991 Oct;31(10):33-6.
9
AIBP reduces atherosclerosis by promoting reverse cholesterol transport and ameliorating inflammation in apoE mice.AIBP 通过促进载脂蛋白 E 小鼠的胆固醇逆转运和改善炎症来减少动脉粥样硬化。
Atherosclerosis. 2018 Jun;273:122-130. doi: 10.1016/j.atherosclerosis.2018.03.010. Epub 2018 Mar 10.
10
Apolipoprotein AI and HDL(3) inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC42.载脂蛋白AI和高密度脂蛋白(HDL(3))通过一种涉及胆固醇消耗和细胞分裂周期蛋白42(CDC42)调节的机制来抑制原代人单核细胞的扩散。
Atherosclerosis. 2001 Dec;159(2):313-24. doi: 10.1016/s0021-9150(01)00518-4.

引用本文的文献

1
The Level of Apolipoprotein A-I Is Associated with a Prognosis in Patients with Chronic Heart Failure Especially in HFmrEF and HFpEF: A Retrospective Cohort Study.载脂蛋白A-I水平与慢性心力衰竭患者尤其是射血分数保留的心力衰竭(HFpEF)和射血分数中间值的心力衰竭(HFmrEF)患者的预后相关:一项回顾性队列研究。
Int J Gen Med. 2025 Aug 25;18:4735-4751. doi: 10.2147/IJGM.S531156. eCollection 2025.
2
FGF21 and APOA1 mRNA-based therapies for the treatment of experimental acute pancreatitis.基于FGF21和APOA1 mRNA的疗法治疗实验性急性胰腺炎。
J Transl Med. 2025 Jan 27;23(1):122. doi: 10.1186/s12967-025-06129-7.
3
Monocytes to Apolipoprotein A1 ratio is associated with metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus.

本文引用的文献

1
Cholesterol Efflux-Independent Modification of Lipid Rafts by AIBP (Apolipoprotein A-I Binding Protein).载脂蛋白 A-I 结合蛋白(AIBP)通过胆固醇外排非依赖途径对脂筏的修饰作用。
Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):2346-2359. doi: 10.1161/ATVBAHA.120.315037. Epub 2020 Aug 13.
2
Combination of apolipoprotein-A-I/apolipoprotein-A-I binding protein and anti-VEGF treatment overcomes anti-VEGF resistance in choroidal neovascularization in mice.载脂蛋白-A-I/载脂蛋白-A-I结合蛋白与抗VEGF治疗相结合可克服小鼠脉络膜新生血管中的抗VEGF耐药性。
Commun Biol. 2020 Jul 16;3(1):386. doi: 10.1038/s42003-020-1113-z.
3
2型糖尿病患者单核细胞与载脂蛋白A1比值与代谢功能障碍相关脂肪性肝病有关。
Sci Rep. 2024 Dec 28;14(1):31396. doi: 10.1038/s41598-024-82994-4.
4
AIBP protects drug-induced liver injury by inhibiting MAPK-mediated NR4A1 expression.AIBP通过抑制丝裂原活化蛋白激酶(MAPK)介导的NR4A1表达来保护药物性肝损伤。
iScience. 2024 Sep 12;27(10):110873. doi: 10.1016/j.isci.2024.110873. eCollection 2024 Oct 18.
5
Expression of recombinant human Apolipoprotein A-I in Nicotiana tabacum.重组人载脂蛋白A-I在烟草中的表达。
Bioresour Bioprocess. 2023 Jan 21;10(1):4. doi: 10.1186/s40643-023-00623-w.
6
Dietary Supplementation with Boswellia serrata, Verbascum thapsus, and Curcuma longa in Show Jumping Horses: Effects on Serum Proteome, Antioxidant Status, and Anti-Inflammatory Gene Expression.在场地障碍赛马匹中补充锯叶乳香、毛蕊花和姜黄:对血清蛋白质组、抗氧化状态及抗炎基因表达的影响
Life (Basel). 2023 Mar 10;13(3):750. doi: 10.3390/life13030750.
7
Aqueous Humor Apolipoprotein Concentration and Severity of Diabetic Retinopathy in Type 2 Diabetes.2 型糖尿病患者房水内载脂蛋白浓度与糖尿病视网膜病变严重程度的关系。
Mediators Inflamm. 2022 Nov 10;2022:2406322. doi: 10.1155/2022/2406322. eCollection 2022.
8
Apolipoprotein A1 Enhances Endothelial Cell Survival in an Model of ALS.载脂蛋白 A1 增强肌萎缩侧索硬化症模型中的内皮细胞存活。
eNeuro. 2022 Jul 28;9(4). doi: 10.1523/ENEURO.0140-22.2022. Print 2022 Jul-Aug.
Nϵ-Carboxymethyl-Lysine Deteriorates Vascular Calcification in Diabetic Atherosclerosis Induced by Vascular Smooth Muscle Cell-Derived Foam Cells.
Nε-羧甲基赖氨酸会加剧由血管平滑肌细胞衍生的泡沫细胞诱导的糖尿病动脉粥样硬化中的血管钙化。
Front Pharmacol. 2020 May 15;11:626. doi: 10.3389/fphar.2020.00626. eCollection 2020.
4
The APOA1bp-SREBF-NOTCH axis is associated with reduced atherosclerosis risk in morbidly obese patients.载脂蛋白 A1 结合蛋白-SREBF-NOTCH 轴与病态肥胖患者的动脉粥样硬化风险降低有关。
Clin Nutr. 2020 Nov;39(11):3408-3418. doi: 10.1016/j.clnu.2020.02.034. Epub 2020 Mar 8.
5
Reactive oxygen species production by BP-1,6-quinone and its effects on the endothelial dysfunction: Involvement of the mitochondria.BP-1,6-醌诱导活性氧的产生及其对血管内皮功能障碍的影响:线粒体的参与。
Toxicol Lett. 2020 Apr 1;322:120-130. doi: 10.1016/j.toxlet.2020.01.011. Epub 2020 Jan 14.
6
Foam cell origination from degenerated vascular smooth muscle cells in atherosclerosis: An ultrastructural study on hyperlipidemic rabbits.动脉粥样硬化中泡沫细胞源自退化的血管平滑肌细胞:对高脂血症兔子的超微结构研究
Ultrastruct Pathol. 2020 Jan 2;44(1):103-115. doi: 10.1080/01913123.2019.1711481. Epub 2020 Jan 7.
7
PAK1 expression determines poor prognosis and immune evasion in metastatic renal cell carcinoma patients.PAK1 表达决定转移性肾细胞癌患者的不良预后和免疫逃逸。
Urol Oncol. 2020 Apr;38(4):293-304. doi: 10.1016/j.urolonc.2019.10.010. Epub 2019 Dec 27.
8
Neuropilin-1 Expression on CD4 T Cells Is Atherogenic and Facilitates T Cell Migration to the Aorta in Atherosclerosis.CD4 T 细胞上的神经纤毛蛋白-1 表达具有动脉粥样硬化形成作用,并促进 T 细胞向动脉粥样硬化的主动脉迁移。
J Immunol. 2019 Dec 15;203(12):3237-3246. doi: 10.4049/jimmunol.1900245. Epub 2019 Nov 18.
9
Associations Between Apolipoprotein A1, High-Density Lipoprotein Cholesterol, and Urinary Cytokine Levels in Elderly Males and Females.老年人中载脂蛋白 A1、高密度脂蛋白胆固醇与尿细胞因子水平的相关性。
J Interferon Cytokine Res. 2020 Feb;40(2):71-74. doi: 10.1089/jir.2019.0074. Epub 2019 Oct 10.
10
Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation.载脂蛋白 AI 通过抑制骨髓生成和斑块炎症促进糖尿病小鼠的动脉粥样硬化消退。
Circulation. 2019 Oct;140(14):1170-1184. doi: 10.1161/CIRCULATIONAHA.119.039476. Epub 2019 Sep 30.